Concepedia

Geoff Mellor

GM

Statistics

Publications

5

Citations

430

H-Index

5

Active since

2001

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Geoff Mellor is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacology, ligand binding, and drug discovery.

Publications per year

2001–2011

5

Publications

5

Attenuation of Murine Collagen-Induced Arthritis by a Novel, Potent, Selective Small Molecule Inhibitor of IκB Kinase 2, TPCA-1 (2-[(Aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), Occurs via Reduction of Proinflammatory Cytokines and Antigen-Induced T Cell Proliferation

Patricia L. Podolin, James F. Callahan, Brian Bolognese et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 299 citations

, , +17

Selectivity of Kinase Inhibitor Fragments

Paul Bamborough, Murray J. B. Brown, J.A. Christopher et al. · Journal of Medicinal Chemistry · 2011 · 66 citations · Full text

, , +17

4-Phenyl-7-azaindoles as potent and selective IKK2 inhibitors

John Liddle, Paul Bamborough, Michael D. Barker et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 28 citations · Full text

, , +9

Site Distribution in Resin Beads as Determined by Confocal Raman Spectroscopy

Jürgen Kress, Abigail Rose, Jeremy G. Frey et al. · Chemistry - A European Journal · 2001 · 26 citations

, , +15

The discovery and initial optimisation of pyrrole-2-carboxamides as inhibitors of p38α MAP kinase

Kenneth Down, Paul Bamborough, Catherine M. Alder et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 11 citations · Full text

, , +12

1–5 of 5